Ginkgo biloba for Prevention of Acute Mountain Sickness: Does It Work?

被引:13
作者
van Patot, Martha C. Tissot [1 ,2 ]
Keyes, Linda E. [2 ]
Leadbetter, Guy, III [3 ]
Hackett, Peter H. [2 ,4 ]
机构
[1] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Surg, Div Emergency Med, Altitude Res Ctr, Denver, CO USA
[3] Mesa State Coll, Dept Exercise Physiol, Grand Junction, CO USA
[4] Inst Altitude Med, Telluride, CO USA
关键词
Gingko biloba; hypoxia; acute mountain sickness; oxidative stress; herbal medicine; PLATELET-ACTIVATING-FACTOR; EXPERIMENTALLY DIABETIC-RATS; EXTRACT EGB 761; IN-VIVO; OXIDATIVE STRESS; GINGKO-BILOBA; HIGH-ALTITUDE; ZINGIBER-OFFICINALE; ENZYME-ACTIVITIES; NITRIC-OXIDE;
D O I
10.1089/ham.2008.1085
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Tissot van Patot, Martha, Linda E. Keyes, Guy Leadbetter III, and Peter H. Hackett. Ginkgo biloba for the prevention of acute mountain sickness: does it work? High Alt. Med. Biol. 10:00-00, 2009.-We review the current literature regarding the prophylactic use of Ginkgo biloba extract (GBE) in acute mountain sickness (AMS). We compare studies with regard to GBE dose, composition, study design, altitude reached, ascent rate, exercise, and risk of AMS. We then review what is known about the active components of GBE and their biological effects and apply this knowledge to interpret the results of AMS prevention trials. Overall, the literature suggests that due to the complexity of GBE the standardization of the product is inadequate, which likely explains the disparate clinical results. The variability in commercially available GBE products makes it impossible to determine whether GBE is truly effective for preventing or ameliorating AMS. However, investigating the roles of specific active components of GBE in the prevention of AMS could yield rewards both clinically and in our understanding of the pathophysiology of AMS.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 164 条
[1]   Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat [J].
Abdel-Salam, OME ;
Baiuomy, AR ;
El-batran, S ;
Arbid, MS .
PHARMACOLOGICAL RESEARCH, 2004, 49 (02) :133-142
[2]   Neuroprotective effects of Ginkgo biloba extract [J].
Ahlemeyer, B ;
Krieglstein, J .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (09) :1779-1792
[3]  
Ahlemeyer B, 2003, PHARMACOPSYCHIATRY, V36, pS8
[4]   Neuroprotective effects of NV-31, a bilobalide-derived compound:: evidence for an antioxidative mechanism [J].
Ahlemeyer, B ;
Junker, V ;
Hühne, R ;
Krieglstein, J .
BRAIN RESEARCH, 2001, 890 (02) :338-342
[5]   Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents [J].
Ahlemeyer, B ;
Möwes, A ;
Krieglstein, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) :423-430
[6]   Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C [J].
Ahlemeyer, B ;
Selke, D ;
Schaper, C ;
Klumpp, S ;
Krieglstein, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (01) :1-7
[7]   Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat [J].
Akisü, M ;
Kültürsay, N ;
Coker, I ;
Hüseyinov, A .
BIOLOGY OF THE NEONATE, 1998, 74 (06) :439-444
[8]   Ginkgo biloba extract regulates differentially the cell death induced by hydrogen peroxide and simvastatin [J].
Altiok, N ;
Ersoz, M ;
Karpuz, V ;
Koyuturk, M .
NEUROTOXICOLOGY, 2006, 27 (02) :158-163
[9]   Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human saphenous vein endothelium [J].
Arnould, T ;
Michiels, C ;
Janssens, D ;
Berna, N ;
Remacle, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (03) :456-463
[10]   Acute mountain sickness: Controversies and advances [J].
Bartsch, P ;
Bailey, DM ;
Berger, MM ;
Knauth, M ;
Baumgartner, RW .
HIGH ALTITUDE MEDICINE & BIOLOGY, 2004, 5 (02) :110-124